Authors
Bykova E. M.
Junior Researcher1
Rumiantseva E. V.
Researcher1
Rud'ko E. A.
PhD, Department Head1
Kochkina N. V.
PhD, Laboratory Head1
Aksenov A. V.
PhD, Assistant Professor, Laboratory Head1
1 - Scientific Center «Signal», 107014, Moscow, Bolshaya Olen'ya str., 8
Corresponding Author
Bykova Elena Michailovna.; e-mail: bykova2016.bykova@yandex.ru
Conflict of interest
None declared.
Funding
The study had no sponsorship.
Abstract
The article presents the results of experimental studies on the development of the optimal composition and technology for production of capsules with dry extract of astaxanthin from seaweed Haematococcus pluvialis, for medicamental prevention and complex treatment of glaucoma. The resulting capsules meet the requirements of the State Pharmacopoeia (XIII edition) for the dosage form.
Key words
astaxanthin, granulate, wet granulation, solid gelatin capsules, glaucoma
DOI
References
1. Openkova E.Yu. et al. Analiz sostoyaniya biohimicheskih pokazatelej v syvorotke krovi i sleznoj zhidkosti u bol'nyh pervichnoj otkrytougol'noj glaukomoj [Analysis of the state of biochemical parameters in the serum and tear fluid in patients with primary open-angle glaucoma]. Klinicheskaya laboratornaya diagnostika [Clinical laboratory diagnostics] 2013; (5): 8-11. (In Russ.)
2. Filina A.A. Antioksidantnaya terapiya pervichnoj glaukomy [Antioxidant Therapy for Primary Glaucoma] Vestnik oftal'mologii [Ophtalmological Bulletin] 1994; (1): 33-35. (In Russ.)
3. Sazontova T.G. Antioksidanty i prooksidanty – dve storony odnogo celogo. Ch. 1 [Antioxidants and prooxidants – two sides of one whole. Pt. 1]. Profilaktika today [Prevention today] 2007: 18-23. (In Russ.)
4. Setkina S.B., Hishova O.M. Biofarmacevticheskie aspekty tekhnologii lekarstvennyh sredstv i puti modifikacii biodostupnosti [Biopharmaceutical aspects of drug technology and ways of modifying bioavailability]. Vestnik VGMU 2014; 13 (4): 162-172. (In Russ.)
5. Samojlova M.V. Vliyanie astaksantina kak sil'nejshego antioksidanta na organizm cheloveka [Effect of astaxanthin as the strongest antioxidant on the human body]. Zdorov'e i obrazovanie v XXI veke [Health and education in the 21st century] 2015; (1): 102-107. (In Russ.)
6. Pechinskij S.V., Kuregyan A.G. Vliyanie karotinoidov na immunitet [The effect of carotenoids on immunity]. Himiko-farmacevticheskij zhurnal [Chemical and Pharmaceutical Journal] 2013; 47 (10): 3-8. (In Russ.)
7. Gosudarstvennaya farmakopeya RF XIII izdaniya. Tom II. [State Pharmacopoeia of the Russian Federation, XIII Edition. Vol. 2]. FEMB.RU: Federal'naya ehlektronnaya medicinskaya biblioteka [FEMB.RU: Federal Electronic Medical Library] 2015. URL: http://193.232.7.120/feml/clinical_ref/pharmacopoeia_2/HTML Cited: 17.07.2018. (In Russ.)
8. Kapelli B., Cisevski G.R. Prirodnyj Astaksantin: korol' karotinoidov [Natural Astaxanthin: the king of carotenoids]. Moscow: NPO «Istochnik dolgoletiya», 2008. (In Russ.)
9. Gazizova I.R. Korrekciya mitohondrial'noj disfunkcii kak osnova nejroprotekcii pri glaukome [Correction of mitochondrial dysfunction as the basis of neuroprotection in glaucoma]. Oftal'mologicheskie vedomosti [Ophtalmologic Vedomosti] 2011; 4 (4): 63-69. (In Russ.)
10. Men'shutina N.V., Mishina Yu.V., Alves S.V. Innovacionnye tekhnologii i oborudovanie farmacevticheskogo proizvodstva. T. 1 [Innovative technologies and equipment for pharmaceutical production. Vol. 1]. Moscow: BINOM, 2012. (In Russ.)
11. Nesterov A.P. Glaukoma [Glaucoma]. Moscow: Medicina, 1995. (In Russ.)
12. Chernyh V.V. et al. Osobennosti patogeneza pervichnoj otkrytougol'noj glaukomy s normalizovannym vnutriglaznym davleniem, novye podhody k kompleksnomu lecheniyu [Features of the pathogenesis of primary open-angle glaucoma with normalized intraocular pressure, new approaches to complex treatment]. Byulleten' SO RAMN [SO RAMN Bulletin] 2014; 34 (3): 6-12. (In Russ.)
13. Nesterov A.P. Pervichnaya otkrytougol'naya glaukoma: patogenez i principy lecheniya [Primary open-angle glaucoma: pathogenesis and treatment principles]. Klinicheskaya oftal'mologiya [Clinical Ophthalmology] 2000; (1): 4-5. (In Russ.)
14. Zalesskaya T.I., Aver V.V., Mandrik K.A. Perekisnoe okislenie belkov plazmy krovi u bol'nyh glaukomoj [Peroxidation of plasma proteins in patients with glaucoma]. Original'nye issledovaniya. Zhurnal GrGMU [Original Studies. Journal of GrGMU] 2007; (3): 66-68. (In Russ.)
15. Mosunova E.P. et al. Sovremennye podhody k farmakoterapii vozrastnoj oftal'mopatologii [Modern approaches to pharmacotherapy of age-related ophthalmopathology]. Vyatskij medicinskij vestnik [Vyatka Medical Bulletin] 2009; (2): 20-26. (In Russ.)
16. Urakov A.L., Urakova N.A., Chernova L.V. Sposob skrininga antigipoksantov [Method for screening of antihypoxants]. Uspekhi sovremennogo estestvoznaniya [Successes of modern natural scienses] 2014; (9): 24-27. (In Russ.)
17. Pechinskij S.V., Kuregyan A.G. Struktura i biologicheskie funkcii karotinoidov [Structure and biological functions of carotenoids]. Voprosy biologicheskoj, medicinskoj i farmacevticheskoj himii [Issues of biological, medical and pharmaceutical chemistry] 2013; (9): 4-15. (In Russ.)
18. Petrov S.Yu. et al. Ehtiologiya pervichnoj glaukomy: sovremennye teorii i issledovaniya [Etiology of primary glaucoma: current theories and research]. Oftal'mologicheskie vedomosti [Ophtalmologic Vedomosti] 2015; 8 (2): 47-56. (In Russ.)
19. Iwamoto T., Hosada K., Hirano R., Kurata H., Matsumoto A., Mikki W., Kamiyama M., Itakura H., Yamamoto S., Kondo K. Inhibition of low-density lipo-protein oxidation by astaxanthin. Journal of Atherosclerosis thrombosis 2000; 7 (4): 216-222.
20. Sandesh Kamath B. Biotechnological production of microalgal carotenoids with reference to astaxanthin and evaluation of its biological activity. Dis. by D.Ph. – Department of Biotechnology of University of Mysore, India, 2007.
21. Shiratori K., Ogami K., Nitta T. The effects of Astaxanthin on Accommodation and Asthenopia-Efficañy-Identification Study in Healthy Volunteers. Clinical Medicine 2005; 21 (6): 637-650.
